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Variation in the nuclear effects of
infection by different human
rhinovirus serotypes
Erin J. Walker, Lora M. Jensen, Sarah Croft and Reena Ghildyal*
Centre for Research in Therapeutic Solutions, Faculty of Education, Science, Technology and Mathematics, University of
Canberra, Canberra, ACT, Australia
Human rhinovirus (HRV) is a positive sense RNA virus, which, despite replicating in
the cytoplasm, has a significant impact on nuclear transport and nuclear localization of
host proteins. A number of studies have identified differences between HRV serotypes,
with respect to host response, protease activity and replicative ability. Here we report
the sero-specific effects of two group-A HRV serotypes, the minor group HRV2
and the major group HRV16, on nuclear transport and nuclear protein localization.
Using Western analysis, immunofluorescence and real time PCR, we show that HRV2
replicates at a faster rate than HRV16, which correlates with earlier production of viral
proteases and disruption of host nuclear transport. There is significant variation in
the nuclear effects of different rhinovirus species, which in turn may impact disease
progression and patient response.
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Introduction
Human rhinovirus (HRV) is a positive sense RNA virus within the Enterovirus genus, which
belongs to the Picornaviridae family. There are >100 strains of HRV, which have variously been
categorized by their response to anti-viral compounds (Andries et al., 1990), the speciﬁc cell
receptor used for entry into host cells [major group: intercellular adhesion molecule 1 (ICAM1) or
minor group: low-density lipoprotein receptor (LDLR)] (Vlasak et al., 2005), or more recently, by
genomic sequence analysis (currently categorized into HRV-A, HRV-B, and HRV-C) (Palmenberg
et al., 2009).
Despite being a positive sense RNA virus with a wholly cytoplasmic replication cycle, HRV
proteins are known to interact signiﬁcantly with the host nucleus, both to alter and utilize host
proteins for viral polyprotein production, as well as subverting the host immune response and
shutting down host transcription and translation. These processes are achieved via the activity of
the virally encoded proteases, 2Apro and 3Cpro, and involve the cleavage of speciﬁc host nuclear and
nuclear-pore proteins (Bushell et al., 2001; Gustin and Sarnow, 2002; Amineva et al., 2004; Watters
and Palmenberg, 2011; Walker et al., 2013).
A number of studies have examined the diﬀerences between HRV serotypes, considering
both protease activity as well as host cytokine response. A study of recombinant 2Apro
activity in vitro from diﬀerent serotypes demonstrated that the protease activity of 2A against
speciﬁc host cell proteins varies with HRV-A > HRV-C >> HRV-B (Watters and Palmenberg,
2011). In addition, in vitro cleavage of host nuclear proteins during infection with HRV16
(Group A) occurred earlier than cleavage by HRV14 (Group B) (Watters and Palmenberg,
2011). Others have examined the eﬀect of HRV species on cytokine response, identifying
Frontiers in Microbiology | www.frontiersin.org 1 August 2015 | Volume 6 | Article 875
Walker et al. Nuclear effects of human rhinovirus infection
signiﬁcant variation in cytokine production associated with HRV
serotype (Nakagome et al., 2014; Rajan et al., 2014). Furthermore,
there is some clinical data to support the notion that HRV-A
viruses cause more severe clinical disease compared to HRV-B
viruses (Iwane et al., 2011; Lee et al., 2012).
The few published studies comparing major and minor
HRV serotypes within the same group have identiﬁed reduced
replicative ability in minor HRV serotypes compared to major
HRV serotypes, as well as variation in disease severity and
cytokine response (Wark et al., 2009; Schuler et al., 2014).
Since it is evident that signiﬁcant variation exists between HRV
serotypes even within the same group, both in terms of viral
protease activity and host response, we examined the eﬀect of a
major and minor group HRV-A virus on host nuclear transport.
We found infection with the minor group HRV2 resulted in
fully processed viral proteases evident earlier during infection
compared to HRV16, leading to earlier cleavage of host nuclear
pore proteins. Interestingly, we found that infection with HRV2
results in cleavage of nucleolin as well as the relocalization of
SC35, as has been previously described for HRV16. Finally we
found the HRV2-induced relocalization of hnRNP-C1/C2 occurs
at least 3 h prior to that induced by HRV16 infection, timing




The primary antibodies for the following proteins were used for
Western analysis and immunoﬂuorescence (IF): anti-Nup62 (BD
Biosciences #610497, used at 1:2000 for Western), anti-Nup98
(Abcam #45584, used at 1:1000 for Western), anti-Nup153
(Abcam #96462, used at 1:1000 for Western), anti-eIF4G (BD
Biosciences #610536, used at 1:1000 for Western), anti-PABP
(Cell Signaling Technology #4992, used at 1:1000 for Western),
anti-nucleolin (Abcam #22758, used at 1:3000 for Western), anti-
hnRNP-C1/C2 (Santa Cruz #32308, used at 1:500 for IF), anti-
SC35 (Sigma #4045, used at 1:500 for IF), anti-Sam68 (Santa Cruz
#sc333, used at 1:500 for IF), and anti-α/β-tubulin (Cell Signaling
Technology #2148, used at 1:1000 for Western). Antibodies to
3Cpro were kindly provided by S. Amineva (Madison, WI, USA;
Amineva et al., 2004) and antibodies to dsRNA were kindly
provided by S. Bowden (VIDRL, Melbourne, VIC, Australia).
Cell Culture and Infection
Ohio-HeLa cells (provided by Bo Lin, Biota Holdings) and A549
cells (ATCC) were grown in high glucose DMEM supplemented
with 10% heat inactivated Foetal Bovine Serum (FBS) and
antibiotics (penicillin, streptomycin, neomycin) at 37◦C in a
humidiﬁed atmosphere of 5% CO2. For HRV infection of
A549 cells, 20 mM MgCl2 was added to the infection media.
Rhinovirus serotype 16 (HRV16) was a gift from E. Dick and W.
Busse (Madison, WI, USA) and Rhinovirus serotype 2 (HRV2)
was provided by Biota Holdings. Viral stocks were prepared
by infecting subconﬂuent monolayers of Ohio-HeLa cells at a
multiplicity of infection (MOI) of 1 by absorption for 1 h with
occasional rocking, followed by replacement of the medium
with fresh DMEM supplemented with 2% FBS and antibiotics.
Once extensive cytopathic eﬀects were observed, infected cultures
were frozen at –80◦C to release virus (Ghildyal et al., 2005).
Cultures were thawed, vortexed and clariﬁed of cellular debris
by centrifugation for 15 min at 3,500 rpm. Infectious virus was
titrated on Ohio-HeLa cells by standard TCID50 protocol and
titre calculated using the Spearman–Karber equation (Mahy and
Kangro, 1996).
Western Analysis
Overnight subconﬂuent cultures of Ohio-HeLa or A549 cells with
or without infection with HRV2 or HRV16 at anMOI of 1 (Ohio-
HeLa cells) or 5 (A549 cells) were lysed at diﬀerent times by
incubation in RIPA buﬀer containing protease and phosphatase
inhibitors (Roche) for 30 min on ice (Walker et al., 2013), prior to
heating at 100◦C for 5 min in Laemmli buﬀer (Hames, 1998). Cell
lysates were subjected to SDS-polyacrylamide electrophoresis
using pre-cast gradient (4–20%) or 10% acrylamide gels (Bio-
Rad, TGX gels) followed by Western transfer to nitrocellulose
membranes in Tris-Glycine-ethanol buﬀer (25 mM Tris-HCl,
192 mM Glycine, 20% Ethanol) for 90 min at 400 mA. Blots
were stained with Ponceau S (Sigma) to conﬁrm transfer and
blocked for 1 h in 4% skim milk (Diploma) in PBS (10 mM
Na2HPO4, 1.7 mM KH2PO4, pH 7.2, 2.7 mM KCl, 137 mM
NaCl), prior to incubation with diﬀerent primary antibodies
diluted in 1% skim milk in PBS-T (PBS containing 0.1% Tween
20) overnight at 4◦C with rocking. After washing in PBS-T,
blots were incubated with species speciﬁc secondary antibodies
conjugated to horseradish peroxidase diluted 1:5000 in 1% skim
milk in PBS-T, followed by washing and detection of bound
antibodies with Enhanced Chemiluminescence (ECL, Perkin
Elmer). Protein bands were detected using the Licor OdysseyFc,
and captured digital images were analyzed using ImageStudio
to quantitate relative protein levels. Where required, blots were
stripped to remove bound antibodies (2% SDS, 62.5 mM Tris-
HCl pH 6.8, 114.4 mM β-mercaptoethanol) at 50◦C for 10 min,
washed in PBS-T, blocked in 4% skim milk in PBS and reprobed
using diﬀerent primary antibodies as required.
Immunofluorescence
Overnight subconﬂuent monolayers of Ohio-HeLa or A549 cells
grown on glass coverslips (Proscitech, #1) were infected with
HRV16 or HRV2 at an MOI of 1 (Ohio-HeLa cells) or 5 (A549
cells) or left uninfected (mock) and ﬁxed with 4% formaldehyde
in PBS followed by permeabilization of cell membranes with
0.2% Triton X-100 in PBS at various times post infection
(p.i.) (Ghildyal et al., 2005). Cells were incubated with primary
antibodies diluted in PBS for 30 min, washed twice in PBS,
incubated with species speciﬁc secondary antibodies conjugated
to CF 488 (Biotium) or Alexa Fluor 568 diluted 1:1000 in
PBS for 30 min, and then washed twice in PBS and mounted
using ProLong Gold mounting media with DAPI (Invitrogen).
Digitized ﬂuorescent cell images were collected using a Nikon Ti
Eclipse confocal laser-scanning microscope (CLSM) with Nikon
60×/1.40 oil immersion lens (Plan Apo VC OFN25 DIC N2;
optical section of 0.5 μm) and the NIS Elements AR software.
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Quantitative analysis of the ﬂuorescence signal in the nucleus
(Fn) and cytoplasm (Fc) was performed using ImageJ.
RNA Isolation and Real Time PCR Analysis
Overnight subconﬂuent cultures of Ohio-HeLa or A549 cells
were infected as described above and RNA was collected
using Tri-Reagent (Sigma). Two samples were collected for
each infection time point. At the indicated times, media was
completely removed and 500 μL of Tri-Reagent was added
to each 35 mm dish. Cell lysate was collected in 1.5 mL
Eppendorf tubes and frozen at –80◦C for subsequent analysis.
Samples were thawed on ice, 100 μL of chloroform was
added and samples were vortexed brieﬂy, then incubated on
ice for 2 min. Samples were then centrifuged at 10,000 rpm
for 15 min at 4◦C. The aqueous layer was transferred to a
new tube and an equal volume of isopropanol was added.
Samples were vortexed and the RNA allowed to precipitate
overnight at –20◦C. The next day, RNA samples were centrifuged
at 10,000 rpm for 10 min at 4◦C to pellet the RNA. The
pellets were washed with 1 mL of 75% ethanol in DEPC
water, vortexed and centrifuged at 7,500 rpm for 5 min
at 4◦C. All ethanol was removed and pellets were left to
dry at room temperature. Dried pellets were resuspended in
15–30 μL of DEPC-water, depending on the size of the pellet.
RNA concentration was determined using a NanoDrop 1000
instrument. To generate cDNA, 1 ug from each sample/time
point was combined to transcribe a total of 2 ug of RNA per
time point. Reverse transcription reactions were performed using
the High Capacity cDNA Reverse Transcription kit (Applied
Biosystems), following the manufacturer’s instructions. Real time
PCR was performed on a Bio-Rad CFX96 instrument, using
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) as per
the manufacturer’s instructions, with the following additions:
cDNA samples were diluted 1:50 prior to analysis, and the
standard curve was generated by combining cDNA from each
sample, then diluted ﬁvefold to generate a 5 sample standard
curve. Samples were ampliﬁed in duplicate and resultant real
time PCR data was analyzed using CFXManager (Bio-Rad). PCR
primer sequences for viral RNA and GAPDH are available on
request.
Statistical Analysis
GraphPad Prism 6 was used for analyses; a two-tailed Mann–
Whitney test was used to assess signiﬁcant diﬀerences in Fn/c
values for hnRNP-C1/C2 and Sam68 localization, compared to
mock samples.
Results
Production of HRV2 Viral Proteins Occurs
Earlier during Infection Compared to HRV16
The production of the viral proteases 2A and 3C during the
course of Ohio-HeLa infection with HRV2 and HRV16 was
assessed by Western blot (Figure 1), with the percentage of
full length protein remaining relative to 0 h.p.i (hours post
infection) shown under the appropriate lane. Quantitation for
HRV2 infection at 24 h.p.i is not shown, as there was a signiﬁcant
decrease in tubulin which caused skewing of the results. However,
the overall trend is apparent. The production and activity of
3Cpro was assessed by direct detection with an anti-3C antibody
as well as by monitoring the appearance of cleavage products
for a known target of 3Cpro, poly(A)-binding protein (PABP).
The production and activity of 2Apro was assessed by monitoring
the appearance of cleavage products of a known 2Apro target,
eukaryotic initiation factor 4G (eIF4G).
Despite infecting Ohio-HeLa cells at the same MOI,
production of active viral proteases was noticeably diﬀerent
between HRV2 and HRV16. In HRV2 infected cells, 3Cpro was
detectable by 6 h.p.i, with the greatest amount of HRV2 3Cpro
present at 9 h.p.i; this coincides with the level of full length PABP,
where 55% remains at 6 h.p.i and only 19% at 9 h.p.i. In HRV16
infected cells, 3Cpro was detectable from 6 h.p.i, though at lower
levels compared to HRV2 infected cells at the same time p.i.
The greatest amount of HRV16 3Cpro is observed at 24 h.p.i,
which coincides with the greatest quantity of PABP cleavage
products.
A similar diﬀerence in also observed for 2Apro, where the
appearance of eIF4G cleavage products (as a proxy for detecting
2Apro directly) was observed from 3 h.p.i in HRV2 infection,
while for HRV16 infection these cleavage products were observed
from 6 h.p.i. In addition, the rate of eIF4G cleavage appeared
to be faster in HRV2 infection, with only 4% of full length
eIF4G remaining at 9 h.p.i, while 26% of full length eIF4G
still remained at 24 h.p.i after HRV16 infection. Similar results
were observed for A549 cells at 24 h.p.i, where 3C and 3CD
can be detected for both HRV2 and HRV16 infection. Cleavage
of eIF4G was only observed for HRV2 infection, a result
that mirrors the time diﬀerence seen in Ohio-HeLa infection
(Supplementary Figure S1A).
HRV Protease Activity Against Host Nuclear
Pore Proteins is Delayed in HRV16 Infection
Since there were obvious diﬀerences in the rate of protease
production as well as in the proteolytic activity of the
proteases from diﬀerent serotypes, we next examined the
eﬀect of HRV2 and HRV16 infection on the cleavage of
speciﬁc nucleoporins (Nups) in Ohio-HeLa cells, as well as
on a nucleolar protein, nucleolin. Representative Western
blots are shown in Figure 2, with the percentage of full
length protein remaining relative to 0 h.p.i shown under the
appropriate lane. HRV16-mediated cleavage of Nups 62, 98,
153, and nucleolin was delayed compared to HRV2. Analysis
of Nup62 in HRV2 infected cells demonstrated that 55% of
the protein remained at 6 h.p.i, and only 28% at 9 h.p.i.
In contrast, HRV16-mediated degradation of Nup62 began
between 9 and 24 h.p.i, as 79% of Nup62 was still apparent at
24 h.p.i.
Cleavage of Nup98 also began earlier in HRV2 infected
cells, with results similar to those observed for Nup62, where
approximately 50% of the full length protein had been cleaved
by 6 h.p.i and only 21% remained at 9 h.p.i. In cells infected with
HRV16, cleavage of Nup98 was apparent by 6 h.p.i, however, at
24 h.p.i, more than 50% of full length protein remained.
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FIGURE 1 | Active proteases are produced at different times after
infection with human rhinovirus 2 or 16 (HRV2 or HRV16). Ohio-HeLa cells
were infected without (mock) or with HRV2 or HRV16 (MOI of 1) and cells lysed
using RIPA buffer containing protease and phosphatase inhibitors at the time
points shown. Cell lysates were subjected to SDS-PAGE on 4–20% gradient
gels (for anti-3C detection) or 10% gels (remaining antibodies) and Western
analysis using the indicated primary antibodies/horseradish peroxidise-
conjugated secondary antibodies and enhanced chemiluminescence (Perkin
Elmer). The approximate protein size (kDa) is shown on the left and the
specificity of the antibodies is indicated on the right. Where cleavage products
are observed, bands corresponding to full length proteins are indicated with
arrowheads and cleavage products are indicated with brackets. cp, cleavage
products; h.p.i, hours post-infection. Results for densitometric analysis of
protein bands are shown below the relevant blots, where data were normalized
to the corresponding values for tubulin, and are shown as the percent protein
remaining relative to the corresponding values for the 0 h sample.
HRV2 appears to cleave Nup153 at a faster rate than HRV16,
as approximately 70% of Nup153 was cleaved in HRV2 infected
cells at 9 h.p.i, compared to less than 20% in HRV16 infected
cells at the same time. Indeed, by 24 h.p.i, 27% of Nup153
(73% remaining) was cleaved in HRV16 infected cells. Together,
these results demonstrate signiﬁcant diﬀerences in the proteolytic
activities of diﬀerent HRV serotypes against speciﬁc host targets.
Finally, analysis of nucleolin showed that although there was
no signiﬁcant loss of full length protein after infection with either
HRV2 or HRV16, a cleavage product was detected from 9 h.p.i
in HRV2 and at 24 h.p.i in HRV16 infected cells. A similar result
was observed for A549 cells at 24 h p.i., where a cleavage product
can be observed in HRV2 infected cells, but not in HRV16
infected cells, again demonstrating the diﬀerence in proteolytic
activity between the two viruses (Supplementary Figure S1B).
The apparent increase in nucleolin during the course of Ohio-
HeLa infection can be explained by our previous results (Walker
et al., 2013), which showed that nucleolin is mislocalized from
nucleoli into the nucleus during infection with HRV16 and
therefore may be more easily detected.
HRV Infection and Mislocalization of Nuclear
Proteins
We next examined the eﬀect of HRV2 and HRV16 infection
on the nuclear localization of speciﬁc proteins, using IF to
identify changes in localization. Ohio-HeLa cells were grown on
coverslips and infected with HRV2 or HRV16 or mock infected,
then ﬁxed at indicated times post-infection. Cells were co-stained
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FIGURE 2 | Human rhinovirus protease activity occurs at different times
after infection with HRV2 or HRV16. Cell lysates were prepared and
subjected to Western analysis as for Figure 1. The specificity of the antibodies
is indicated on the right. Where cleavage products are observed, bands
corresponding to full length proteins are indicated with arrowheads and
cleavage products are indicated with brackets. cp, cleavage products; h.p.i,
hours post-infection. Results for densitometric analysis of protein bands are
shown below the relevant blots, where data were normalized to the
corresponding values for tubulin, and are shown as the percent protein
remaining relative to the corresponding values for the 0h sample.
for dsRNA to identify infected cells and speciﬁc nuclear proteins
as indicated (Figure 3). Figure 3A shows the eﬀect of HRV
infection on nuclear speckle protein SC35. At 6 h after HRV2
infection, the SC35 staining was fainter and less obvious, though
the protein was still present in small nuclear speckles. By 9 h.p.i,
SC35 had become diﬀuse throughout the nucleus. A similar eﬀect
was observed in HRV16 infected cells, where at 6 h.p.i SC35
speckles were fainter than mock infection, and by 9 h.p.i SC35
was diﬀuse throughout the nucleus. Thus, in contrast to results
observed for HRV14 (Gustin and Sarnow, 2002), cleavage or
degradation of the nuclear speckle protein SC35 was observed in
both HRV2 and HRV16 infected cells.
Examination of hnRNP-C1/C2 by IF (Figure 3B) showed
limited nuclear mislocalization of hnRNP-C1/C2 at 6 h.p.i
in HRV2 infected cells. However by 9 h.p.i, there was
signiﬁcant mislocalization of hnRNP-C1/C2 into the cytoplasm.
Quantitation of nuclear compared to cytoplasmic ﬂuorescence
(Fn/c, Figure 4A) conﬁrmed a moderately signiﬁcant diﬀerence
in localization at 6 h.p.i (p < 0.01) and a highly signiﬁcant
diﬀerence at 9 h.p.i (p < 0.0001) compared to mock infection.
A similar trend was also observed for cells infected with HRV16,
however, quantitation showed there was a signiﬁcant decrease
in Fn/c only at 9 h.p.i (p < 0.001) when compared to mock
(Figure 4A).
Figure 3C depicts HRV2 and HRV16 infected cells stained for
the nuclear protein Sam68. Mislocalization of Sam68 from the
nucleus into the cytoplasm was apparent at all timepoints, and
quantitation of nuclear compared to cytoplasmic ﬂuorescence
(Fn/c, Figure 4B) conﬁrmed this observation, with a highly
signiﬁcant decrease in Fn/c (p< 0.0001) seen for both HRV2 and
HRV16, at 6 and 9 h.p.i.
Together these results suggest that disruption of nuclear
traﬃcking leading to mislocalization of nuclear proteins occurs
early during infection with both HRV2 and HRV16, as SC35
and Sam68 were aﬀected by 6 h.p.i in cells infected with either
serotype. Disruption leading to mislocalization of hnRNP-C1/C2
appears to occur later during infection, as infection with HRV2
at 6 h.p.i led to a small change in nuclear localization compared
to the more signiﬁcant diﬀerence observed at 9 h.p.i for HRV2;
infection with HRV16 had a more subtle eﬀect on hnRNP-C1/C2
localization, with signiﬁcant changes compared to mock only
apparent at 9 h.p.i. While it could be argued that nuclear protein
mislocalization is a result of apoptosis, we have treated Ohio-
HeLa cells with Actinomycin D (5 μg/ml) to induce apoptosis,
followed by staining for SC35, hnRNP-C1/C2 and Sam68 as
described above; no changes in nuclear protein localization were
observed during this treatment (data not shown).
We also examined whether HRV2 and 16 could replicate
in A549 cells, and observed dsRNA in cells infected with both
serotypes at 24 h p.i., indicating replication of the viral genome
(Supplementary Figure S1C).
Viral RNA Replication Occurs Earlier during
Infection with HRV2
To assess the rate of virus replication, the relative amount of
viral RNA in cells infected with HRV2 or HRV16 at speciﬁed
Frontiers in Microbiology | www.frontiersin.org 5 August 2015 | Volume 6 | Article 875
Walker et al. Nuclear effects of human rhinovirus infection
FIGURE 3 | Continued
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FIGURE 3 | Continued
HRV2 and HRV16 infection lead to mislocalization of nuclear proteins.
Ohio-HeLa cells grown on coverslips were infected without (mock) or with
HRV2 or HRV16 as for Figure 1; cells were fixed at the indicated times and
permeabilized, and then probed with (A) anti-dsRNA and anti-SC35 antibodies,
(B) anti-dsRNA and anti-hnRNP-C1/C2 antibodies, or (C) anti-dsRNA and
anti-Sam68 antibodies, followed by CF488 and Alexa-568 conjugated
secondary antibodies. Coverslips were mounted in ProlongGold mounting
media with DAPI. Fluorescence was imaged by CLSM (see Materials and
Methods). White arrows indicate infected cells.
FIGURE 4 | Infection with HRV2 or HRV16 leads to significant
mislocalization of nuclear proteins. The nuclear and cytoplasmic
fluorescence of infected and mock infected cells prepared as in Figure 3 was
quantitated using ImageJ, and the mean Fn/c values were plotted for (A)
hnRNP-C1/C2 and (B) Sam68. Values are shown +SEM. Significance
compared to mock values are shown as ∗p < 0.01, ∗∗p < 0.001, ∗∗∗p < 0.0001.
time points was measured. RNA was collected from HRV2
or HRV16 infected Ohio-HeLa cells, reversed transcribed and
used in real-time PCR reactions, using primers speciﬁc for
HRV viral RNA (Dagher et al., 2004) as well as GAPDH as a
loading control. Data is shown as arbitrary units of viral RNA
relative to GAPDH (Figure 5). These results show a steady
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FIGURE 5 | Viral RNA replication is detectable earlier in HRV2 infection
compared to HRV16 infection. Real-time PCR was used to assess the
quantity of viral RNA present in infected cells at the specified time points for
HRV2 and HRV16 infection. Data is shown as arbitrary units relative to
GAPDH.
increase in HRV2 viral RNA from ∼1 unit at 6 h.p.i to ∼4.5
units at 9 h.p.i and ∼25 units at 24 h.p.i. In contrast, viral
replication after infection with HRV16 appeared to lag behind
HRV2, with <1 unit detected at 9 h.p.i and ∼1.5 units detected
at 24 h.p.i; these results correlate with the lag observed for
protease activity against host proteins (Figures 1 and 2). Given
the results shown in Supplementary Figure S1, we predict that
it should also be possible to detect HRV genomes in infected
A549 cells. Furthermore, since it appears that HRV2 is able
to produce viral proteins and potentially assemble new virions
more quickly than HRV16, we may also expect to observe less
HRV2 viral RNA compared to that generated in HRV16 infected
cells. Indeed, analysis of infected A549 cells at 24 h p.i. shows
both HRV2 and HRV16 are able to replicate in these cells
(Supplementary Figure S2) and there is more HRV16 viral RNA
in cells compared to HRV2 viral RNA.
Discussion
In the current study, we found the minor group HRV2 was
able to replicate more eﬃciently than the major group HRV16
(Figure 5), which resulted in earlier production of viral proteases,
concomitant with earlier cleavage of the target proteins PABP
and eIF4G (Figure 1). In addition, the earlier production of
viral proteases led to earlier and more complete cleavage of
host nuclear pore proteins (Nups) as well as cleavage of the
nucleolar protein, nucleolin (Figure 2). Despite the apparent lag
in replication and therefore protease activity between HRV2 and
HRV16, analysis of IF results (Figures 3 and 4) indicate that
changes occur in the appearance of nuclear speckle protein SC35
by 6 h.p.i with HRV16, as well as signiﬁcantly altering the nuclear
localization of Sam68 at this time. In contrast, the mislocalization
of nuclear protein hnRNP-C1/C2 occurred later, by 9 h.p.i for
HRV2 infection and >9 h.p.i for HRV16 infection, possibly once
complete disruption of the NPC has been achieved.
While picornavirus protease cleavage of PABP, eIF4G, and
Nups is well established (Lamphear et al., 1993; Liebig et al.,
1993; Gustin and Sarnow, 2002; Amineva et al., 2004; Kuyumcu-
Martinez et al., 2004; Watters and Palmenberg, 2011), the eﬀect
on nucleolin beyond mislocalization (Gustin and Sarnow, 2002)
has not been explored in detail. Here we show that infection with
either HRV2 or HRV16 can lead to the presence of a cleavage
product, similar to our previously reported results for HRV16
(Walker et al., 2013). The exact reason for nucleolin cleavage
in HRV infection is unclear, as there are no reports of this
event during infection with other viruses. Indeed, nucleolin has
been reported as the cellular receptor for respiratory syncytial
virus (Tayyari et al., 2011) and has been implicated as a
required interacting protein in a number of other virus infections,
including human cytomegalovirus (Strang et al., 2012), rabies
virus (Oksayan et al., 2015), herpes simplex virus 1 (Greco et al.,
2012), and a member of the picornavirus family, enterovirus 71
(Su et al., 2015). One possibility is that HRV infection initiates
the apoptotic cascade in such a manner that cleavage of nucleolin
is a downstream result, as nucleolin at the approximate size
we observed has been reported to be cleaved by okadaic acid-
induced apoptosis in cell lines (Kito et al., 2003), however, further
investigation is required.
The mislocalization of Sam68 and alteration in the appearance
of SC35 occurred as an early event during infection with both
HRV2 and HRV16, before there was signiﬁcant disruption of
nuclear pore components in either HRV2 or HRV16 infection,
suggesting that either a very small amount of viral protease
activity is required to initiate these changes, or that early
infection events prompt an additional pathway that contributes
to the observed changes. That Sam68 is mislocalized during
picornavirus infection has been well established (McBride et al.,
1996; Gustin and Sarnow, 2002; Walker et al., 2013), however,
HRV-initiated changes in SC35, an essential component of
the spliceosome, have only been reported for HRV16 (Walker
et al., 2013). In the current paper we also describe the same
changes in HRV2 infection; this is in contrast to HRV14 or
poliovirus infection (Meerovitch et al., 1993; Gustin and Sarnow,
2001; Gustin and Sarnow, 2002), where no changes in SC35
appearance were observed. While there is precedent for viruses
that undergo alternative splicing, such as human papilloma virus
(McFarlane and Graham, 2010) and human immunodeﬁciency
virus (Maldarelli et al., 1998), to induce expression of SC35,
the reason for HRV disruption of SC35 is unclear, beyond
general disruption of the host cellular transcription machinery.
It remains to be determined whether alterations in SC35 occur
more generally in HRV infection, or if they are group speciﬁc and
do not occur in Group B HRV.
The mislocalization of hnRNP-C1/C2 in picornavirus
infection has been reported previously (Gustin and Sarnow,
2001; Gustin and Sarnow, 2002) and our results are consistent
with these reports. Interestingly and in contrast to Sam68
and SC35, the timing of hnRNP-C1/C2 mislocalization
varied between HRV2 and HRV16 by at least 3 hours. This
delay in hnRNP-C1/C2 mislocalization better reﬂects the
Frontiers in Microbiology | www.frontiersin.org 8 August 2015 | Volume 6 | Article 875
Walker et al. Nuclear effects of human rhinovirus infection
observed disruption of nuclear pore components, which are
cleaved much earlier in HRV2 infected cells. Thus it is likely
that complete disruption of the nuclear pore and nuclear
traﬃcking is required before hnRNP-C1/C2 is displaced into
the cytoplasm. The reason for this requirement is unclear,
since hnRNP-C1/C2, at ∼40 kDa, is a similar size to both
SC35 (35 kDa) and Sam68 (68 kDa) so all might be expected
to diﬀuse into the cytoplasm at a similar time. Alternatively
it is possible the strong nuclear retention signal carried by
hnRNP-C1/C2 (Nakielny and Dreyfuss, 1996) enables these
proteins to maintain their nuclear localization for longer during
infection.
The impact of HRV serotype on pathogenesis has been
examined by a small number of studies, which have
found diﬀerences in the host immune response to major
vs minor group HRV, as well as reduced cell viability
after infection with minor group HRV (Wark et al., 2009;
Schuler et al., 2014); we also observe greater cell death
in cells infected with minor group HRV2 compared to
major group HRV16 (Supplementary Figure S3). A study
of asthma exacerbation has suggested exposure to minor
Group A HRV is signiﬁcantly associated with exacerbations
(Denlinger et al., 2011), and a recent study by Schuler et al.
(2014) suggests the diﬀerential receptor usage between major
and minor Group A HRV may be a mechanism for the
observed variation in response to diﬀerent HRV serotypes,
though additional studies of multiple HRV serotypes are
required.
Conclusion
This study demonstrates there are clear diﬀerences in the
timing of viral protein production, host protein cleavage and
host protein mislocalization, as well as in the amount of
viral RNA produced, during HRV2 and HRV16 infection. The
mislocalization of some nuclear proteins (SC35 and Sam68)
occurs early after the initial infection, prior to the complete
disruption of the nuclear pore. Other nuclear proteins (hnRNP-
C1/C2) seem to require complete disruption of the nuclear
pore, which may be a consequence of this protein carrying a
strong nuclear retention signal. Future work is aimed at further
investigating the diﬀerences between diﬀerent HRV serotypes
and determining whether the variation observed between HRV2
and HRV16 is similar for other major and minor Group A HRV
serotypes.
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FIGURE S1 | Human rhinovirus effects in A549 cells. (A,B) A549 cells were
infected without (mock) or with HRV2 or HRV16 (MOI of 5) for 24 h and cells lysed
collected and subjected to Western analysis as described in Figure 1. The
approximate protein size (kDa) is shown on the left and the specificity of the
antibodies is indicated on the right. Where cleavage products are observed,
bands corresponding to full length proteins are indicated with arrowheads and
cleavage products are indicated with brackets. cp – cleavage products. (C) A549
cells were grown on coverslips and infected without (mock) or with HRV2 or
HRV16 (MOI of 5). At 24 h p.i. cells were fixed, permeabilized and probed with
anti-dsRNA antibodies, followed by CF488 secondary antibodies. Coverslips were
mounted in ProlongGold mounting media with DAPI. Fluorescence was imaged by
CLSM (see Materials and Methods).
FIGURE S2 | HRV2 and HRV16 replicate in A549 cells. Real-time PCR was
used to assess the quantity of viral RNA present in infected cells at 24 h p.i. for
HRV2 and HRV16 infection. Data is shown as arbitrary units relative to GAPDH.
FIGURE S3 | Cell death after HRV2 or HRV16 infection. Ohio-HeLa cells were
grown in six well plates and were mock infected, or infected with HRV2 or HRV16,
at an MOI of 1. Live cells were imaged at 24 h p.i. using a Leica DMIL light
microscope.
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